Classification of Major Depressive Disorder Using Vertex-Wise Brain Sulcal Depth, Curvature, and Thickness with a Deep and a Shallow Learning Model

📅 2023-11-18
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the limited diagnostic utility of structural neuroimaging for major depressive disorder (MDD), particularly regarding cross-site generalizability. Method: Leveraging the ENIGMA-MDD multisite cohort (N = 7,012), we systematically evaluated the discriminative power of vertex-wise sulcal depth, cortical curvature, and cortical thickness—integrated via feature fusion—for MDD classification. Morphometric features were extracted using FreeSurfer, and models (DenseNet and SVM) were rigorously validated using strict leave-one-site-out cross-validation. Contribution/Results: Both models achieved near-chance balanced accuracy on independent test sites (DenseNet: 51%; SVM: 53%), indicating that current combinations of static structural morphometric features lack robustness and generalizability across centers. This finding underscores a fundamental limitation of unimodal structural biomarkers in clinical translation and provides empirical impetus for integrating functional, connectivity-based, or dynamic neuroimaging features in future MDD diagnostic frameworks.
📝 Abstract
Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in the brain are linked to MDD, likely due to the heterogeneity of this disorder. The application of deep learning tools to neuroimaging data, capable of capturing complex non-linear patterns, has the potential to provide diagnostic and predictive biomarkers for MDD. However, previous attempts to demarcate MDD patients and healthy controls (HC) based on segmented cortical features via linear machine learning approaches have reported low accuracies. Here, we used globally representative data from the ENIGMA-MDD working group containing 7,012 participants from 30 sites (N=2,772 MDD and N=4,240 HC), which allows a comprehensive analysis with generalizable results. Based on the hypothesis that integration of vertex-wise cortical features can improve classification performance, we evaluated the classification of a DenseNet and a Support Vector Machine (SVM), with the expectation that the former would outperform the latter. We found that both classifiers exhibited close to chance performance (balanced accuracy DenseNet: 51%; SVM: 53%), when estimated on unseen sites. Slightly higher classification performance (balanced accuracy DenseNet: 58%; SVM: 55%) was found when the cross-validation folds contained subjects from all sites, indicating site effect. In conclusion, the integration of vertex-wise morphometric features and the use of the non-linear classifier did not lead to the differentiability between MDD and HC. Our results support the notion that MDD classification on this combination of such features and classifiers is unfeasible. Perhaps more sophisticated integration of multimodal information may lead to a higher performance in this diagnostic task.
Problem

Research questions and friction points this paper is trying to address.

Brain Morphology Analysis
Major Depressive Disorder (MDD)
Diagnosis and Treatment Improvement
Innovation

Methods, ideas, or system contributions that make the work stand out.

Deep Learning
DenseNet SVM
MDD Diagnosis
🔎 Similar Papers
No similar papers found.
V
Vladimir Belov
1
T
Tracy Erwin-Grabner
1
L
Ling-Li Zeng
2,3
C
Christopher R. K. Ching
3
A
Andre Aleman
4
A
Alyssa R. Amod
5
Z
Zeynep Basgoze
6
Francesco Benedetti
Francesco Benedetti
PhD student, Università degli studi di Bari Aldo Moro, University of Pisa
Network analysismodel recycling
B
Bianca Besteher
8
K
Katharina Brosch
9
R
Robin Bulow
10
R
Romain Colle
11,12
C
Colm G. Connolly
13
E
Emmanuelle Corruble
11,12
B
Baptiste Couvy-Duchesne
14,15
K
Kathryn Cullen
6
U
Udo Dannlowski
16
C
Christopher G. Davey
17
A
Annemiek Dols
18,19
J
Jan Ernsting
16
J
Jennifer W. Evans
20
L
Lukas Fisch
16
P
Paola Fuentes-Claramonte
21
A
Ali Saffet Gonul
22
I
Ian H. Gotlib
23
H
Hans J. Grabe
24
N
Nynke A. Groenewold
5
D
Dominik Grotegerd
16
T
Tim Hahn
16
J
J. Paul Hamilton
25
L
Laura K.M. Han
26,27
B
Ben J Harrison
17
T
Tiffany C. Ho
28,29
Neda Jahanshad
Neda Jahanshad
Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, ENIGMA, Keck, USC
neuroimagingimaging geneticsdiffusion imagingneuroinformatics
A
Alec J. Jamieson
17
A
Andriana Karuk
21
T
Tilo Kircher
9
B
Bonnie Klimes-Dougan
30
S
Sheri-Michelle Koopowitz
5
Thomas Lancaster
Thomas Lancaster
31,32
R
Ramona Leenings
16
M
Meng Li
8
D
David E. J. Linden
31,32,33,34
F
Frank P. MacMaster
35
D
David M. A. Mehler
16,31,32,36
S
Susanne Meinert
16,37
E
Elisa Melloni
7
B
Bryon A. Mueller
6
Benson Mwangi
Benson Mwangi
38
I
Igor Nenadić
9
A
Amar Ojha
39
Y
Yasumasa Okamoto
40
M
Mardien L. Oudega
41,42
B
Brenda W. J. H. Penninx
41
S
Sara Poletti
7
Edith Pomarol-Clotet
Edith Pomarol-Clotet
21
M
Maria J. Portella
43
E
Elena Pozzi
26,27
Joaquim Radua
Joaquim Radua
44
E
Elena Rodríguez-Cano
21
Matthew D. Sacchet
Matthew D. Sacchet
Associate Professor and Director, Meditation Research Program, Harvard Medical School / Mass General
Advanced MeditationMeditative DevelopmentMeditative EndpointsMindfulness Meditation
Raymond Salvador
Raymond Salvador
21
Anouk Schrantee
Anouk Schrantee
46
Kang Sim
Kang Sim
47,48,49
J
Jair C. Soares
38
A
Aleix Solanes
44
D
Dan J. Stein
5
F
Frederike Stein
9
A
Aleks Stolicyn
50
S
Sophia I. Thomopoulos
3
Y
Yara J. Toenders
26,27,51,52
A
Aslihan Uyar-Demir
22
E
Eduard Vieta
53
Y
Yolanda Vives-Gilabert
54
Henry Völzke
Henry Völzke
Professor für Klinische Epidemiologie, Universitätsmedizin Greifswald